NASDAQ:HJLI - Hancock Jaffe Laboratories Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.40 +0.01 (+0.42 %)
(As of 03/20/2019 04:00 PM ET)
Previous Close$2.39
Today's Range$2.32 - $2.49
52-Week Range$1.31 - $5.64
Volume91,740 shs
Average Volume157,708 shs
Market Capitalization$34.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Hancock Jaffe Laboratories, Inc., a development stage medical device company, develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal, and peripheral arterial diseases in the United States and Europe. The company develops and manufactures implantable cardiovascular bioprosthetic devices for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease. Its products include the Bioprosthetic Heart Valve, a bio-prosthetic heart valve designed to mimic and function like a native heart valve; the CoreoGraft, a device for use as an alternate or supplemental coronary vascular conduit in coronary bypass surgery; and the Venous Valve, a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency. The company was founded in 1987 and is headquartered in Irvine, California. As of July 18, 2006, Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA.

Receive HJLI News and Ratings via Email

Sign-up to receive the latest news and ratings for HJLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HJLI
CUSIPN/A
Phone949-261-2900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$190,000.00
Book Value$0.17 per share

Profitability

Net Income$-13,040,000.00
Net Margins-6,921.70%

Miscellaneous

EmployeesN/A
Market Cap$34.00 million
Next Earnings Date3/20/2019 (Estimated)
OptionableNot Optionable

Hancock Jaffe Laboratories (NASDAQ:HJLI) Frequently Asked Questions

What is Hancock Jaffe Laboratories' stock symbol?

Hancock Jaffe Laboratories trades on the NASDAQ under the ticker symbol "HJLI."

When is Hancock Jaffe Laboratories' next earnings date?

Hancock Jaffe Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, March 20th 2019. View Earnings Estimates for Hancock Jaffe Laboratories.

Has Hancock Jaffe Laboratories been receiving favorable news coverage?

Media headlines about HJLI stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Hancock Jaffe Laboratories earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future.

Who are some of Hancock Jaffe Laboratories' key competitors?

What other stocks do shareholders of Hancock Jaffe Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hancock Jaffe Laboratories investors own include Amarin (AMRN), Lendlease Group (LLC), General Electric (GE), AAR (AIR), Avid Bioservices (CDMO), Micron Technology (MU), Constellation Brands (STZ), Mid-America Apartment Communities (MAA), United States Brent Oil Fund (BNO) and NVIDIA (NVDA).

Who are Hancock Jaffe Laboratories' key executives?

Hancock Jaffe Laboratories' management team includes the folowing people:
  • Dr. Benedict Broennimann M.D., Chief Medical Officer of Outside of United States (Age 62)
  • Dr. Marc H. Glickman, Sr. VP & Chief Medical Officer (Age 70)
  • Mr. Robert A. Berman, CEO & Director (Age 56)
  • Mr. Warren Hancock, Co-founder
  • Mr. Robert Rankin, Chief Financial Officer (Age 66)

When did Hancock Jaffe Laboratories IPO?

(HJLI) raised $8 million in an initial public offering (IPO) on Thursday, May 31st 2018. The company issued 1,500,000 shares at $5.00 per share. Network 1 Financial Securities acted as the underwriter for the IPO and ViewTrade Securities was co-manager.

Who are Hancock Jaffe Laboratories' major shareholders?

Hancock Jaffe Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Jane Street Group LLC (0.27%). View Institutional Ownership Trends for Hancock Jaffe Laboratories.

Which major investors are buying Hancock Jaffe Laboratories stock?

HJLI stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC. View Insider Buying and Selling for Hancock Jaffe Laboratories.

How do I buy shares of Hancock Jaffe Laboratories?

Shares of HJLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Hancock Jaffe Laboratories' stock price today?

One share of HJLI stock can currently be purchased for approximately $2.40.

How big of a company is Hancock Jaffe Laboratories?

Hancock Jaffe Laboratories has a market capitalization of $34.00 million and generates $190,000.00 in revenue each year.

What is Hancock Jaffe Laboratories' official website?

The official website for Hancock Jaffe Laboratories is http://www.hancockjaffe.com.

How can I contact Hancock Jaffe Laboratories?

Hancock Jaffe Laboratories' mailing address is 70 DOPPLER, IRVINE CA, 92618. The company can be reached via phone at 949-261-2900.


MarketBeat Community Rating for Hancock Jaffe Laboratories (NASDAQ HJLI)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  134
MarketBeat's community ratings are surveys of what our community members think about Hancock Jaffe Laboratories and other stocks. Vote "Outperform" if you believe HJLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HJLI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel